DavidsTea Inc (NASDAQ:DTEA) was the recipient of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 886,500 shares, a decrease of 21.7% from the May 30th total of 1,132,800 shares. Approximately 6.4% of the shares of the stock are sold short. Based on an average daily volume of 210,300 shares, the short-interest ratio is presently 4.2 days.
Separately, ValuEngine downgraded Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.
A hedge fund recently raised its stake in DavidsTea stock. Barclays PLC grew its stake in shares of DavidsTea Inc (NASDAQ:DTEA) by 709,971.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 149,115 shares of the company’s stock after acquiring an additional 149,094 shares during the period. Barclays PLC owned about 0.57% of DavidsTea worth $176,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 2.93% of the company’s stock.
DavidsTea (NASDAQ:DTEA) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.19 EPS for the quarter. DavidsTea had a negative return on equity of 13.24% and a negative net margin of 17.25%. The company had revenue of $62.54 million during the quarter.
DAVIDsTEA Inc operates as a retailer of specialty tea in Canada and the United States. The company offers approximately 135 loose-leaf teas, pre-packaged teas, tea sachets and tea-related gifts, and accessories; and food, as well as tea beverages, such as hot or iced tea, and tea lattes. It provides loose-leaf tea in white, green, oolong, black, pu'erh, mate, rooibos, and herbal tea categories.
Featured Article: Trading Strategy Examples and Plans
Receive News & Ratings for DavidsTea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DavidsTea and related companies with MarketBeat.com's FREE daily email newsletter.